|1.||Hoffman, Robert M: 4 articles (01/2012 - 06/2007)|
|2.||Ma, Huaiyu: 2 articles (01/2012 - 06/2007)|
|3.||Zhao, Ming: 2 articles (01/2012 - 06/2007)|
|4.||Gordon, John R: 2 articles (02/2010 - 12/2007)|
|5.||Town, Jennifer R: 2 articles (02/2010 - 12/2007)|
|6.||Zhang, Xiaobei: 2 articles (02/2010 - 12/2007)|
|7.||Zhao, Xixing: 2 articles (02/2010 - 12/2007)|
|8.||Li, Fang: 2 articles (02/2010 - 12/2007)|
|9.||Taevernier, Lien: 1 article (06/2014)|
|10.||Gevaert, Bert: 1 article (06/2014)|
12/01/2011 - "typhimurium A1-R mutant, which is auxotrophic for leu-arg, is tumor-seeking and has antitumor efficacy against the major types of cancer. "
06/01/2010 - "Phage display biopanning identified Gly-Ile-Arg-Leu-Arg-Gly (GIRLRG) as a peptide that selectively recognizes tumors responding to XRT. "
09/01/2009 - "typhimurium A1-R mutant, which is auxotrophic for leu-arg and has high anti-tumor virulence, was developed in our laboratory. "
06/12/2007 - "typhimurium A1-R mutant, which is auxotrophic for leu-arg and has increased antitumor virulence selected by tumor passage. "
06/12/2007 - "We have developed a far more effective bacterial cancer therapy by targeting viable tumor tissue by using Salmonella typhimurium leu-arg auxotrophs. "
09/01/2008 - "aeruginosa infection with greater neutrophil influx into the lungs, increased expression of Glu-Leu-Arg-positive (ELR(+)) CXC chemokines macrophage inflammatory protein-2 and keratinocyte chemoattractant (KC), superior bacterial clearance and improved survival at 24 h after infection. "
01/01/1990 - "Dalargin, an opioid peptide (Tyr-D-Ala-Gly-Phe-Leu-Arg), was shown to significantly inhibit the carcinogenic effect of 50 mg/kg body weight nitrosomethylurea given as single i. v. infection. "
08/01/1988 - "Monoclonal antibodies (MABs) to a new drug Dalargin (Tyr-D-Ala-Gly-Phe-Leu-Arg) enhancing ulcer healing have been produced. "
01/01/1988 - "Pharmacokinetics of a new anti-ulcer drug, synthetic opioid hexapeptide dalargin (Tyr-D-Ala-Gly-Phe-Leu-Arg), which is an analogue of Leu-enkephalin, was studied in rats. "
12/01/1992 - "L-leucyl-L-arginine, naltrindole and D-arginine block antinociception elicited by L-arginine in mice with carrageenin-induced hyperalgesia."
07/01/2007 - "pretreatment of mice with NVP-AAM077 [[(R)-[(S)-1-(4-bromophenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid] (selective antagonist of the NR2A subunit of the NMDAR) or DT-3 [H-Arg-Gln-Ile-Lys-Ile-Trp-Phe-Gln-Asn-Arg-Arg-Met-Lys-Trp-Lys-Lys-Leu-Arg-Lys-Lys-Lys-Lys-Lys-His-OH] (inhibitor of protein kinase G) had no effect on (S)-3,5-DHPG-mediated hyperalgesia. "
|2.||Gonadotropin-Releasing Hormone (GnRH)
|6.||Interferon-gamma (Interferon, gamma)
|10.||Ala(2)- enkephalinamide-Met (DAME)